Key facts
- Molekule’s last known valuation is $308.0M (Feb 2020).
- It has raised $158.2M; the latest was Later Stage VC ($6.6M) in May 2025.
- Notable investors include Trinity Capital (Phoenix).
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Molekule
- ·The full record, as it builds
Funding rounds
No funding rounds for Molekule are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Molekule
Manufacturer of molecular air purification devices intended to revolutionize air purification and bring clean air. The company's devices utilize photoelectrochemically oxidation nanotechnology and machine learning to combat and destroy allergens, mold, bacteria, viruses and airborne chemicals on a molecular level, enabling users to have clean breathable air at home and the workplace.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Palm Beach Gardens, FL, United States
- Founded
- 2014
- Employees
- 81
- Website
- molekule.com/
- Ownership
- Privately Held (backing)
Molekule doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Molekule shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Molekule in its N-PORT filings yet. We sweep new filings monthly.